Abbott Labs Financial Statements
Abbott Labs Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | December |
© 2009 Morningstar, Inc. Financial Data provided by
Abbott Labs Income Statement
| 2008 | 2007 | 2006 | |
|---|---|---|---|
| Revenue ($ mil.) | 29,527.6 | 25,914.2 | 22,476.3 |
| Gross Profit ($ mil.) | 16,915.5 | 14,492.2 | 12,661.2 |
| Operating Income ($ mil.) | 6,384.8 | 5,062.8 | 2,692.5 |
| Total Net Income ($ mil.) | 4,880.7 | 3,606.3 | 1,716.8 |
| Diluted EPS (Net Income) | 3.12 | 2.31 | 1.12 |
Abbott Labs Quarterly Statements
| Quarter Ending Sep 09 | Quarter Ending Jun 09 | Quarter Ending Jun 09 | |
|---|---|---|---|
| Revenue ($ mil.) | 7,761.0 | 7,494.9 | 7,494.9 |
| Gross Profit ($ mil.) | 4,401.0 | 4,365.9 | 4,365.9 |
| Operating Income ($ mil.) | -- | 1,704.0 | 1,704.0 |
| Total Net Income ($ mil.) | 1,480.0 | 1,288.1 | 1,288.1 |
| Diluted EPS (Net Income) | 0.95 | 0.83 | 0.83 |
Abbott Labs Stock Quote & Chart
11/06/09 16:00:44 EST •
NYSE •
51.53
•
 -0.0900
•
-0.1744 %
|
|---|
|
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
|
Abbott Labs Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 2.71 | 2.65 | 7.00 |
| Price/Earnings Ratio | 15.48 | 16.81 | 25.45 |
| Price/Book Ratio | 4.01 | 2.88 | 6.74 |
| Price/Cash Flow Ratio | 12.02 | 10.14 | 43.48 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed Abbott Labs Financial Ratios
Abbott Labs Competitive Intelligence
| Merck | Roche Holding | Sanofi-Aventis | |
|---|---|---|---|
| Annual Sales ($ mil.) | 18,502.0 | 45,355.5 | 40,057.0 |
| Employees | 51,000 | -- | 98,213 |
| Market Cap ($ mil.) | 46,142.1 | 234,796.4 | 97,482.8 |
Competitive Landscape
